BSE Live
Dec 31, 16:01Prev. Close
2725.15
Open Price
2729.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 31, 15:54Prev. Close
2726.90
Open Price
2726.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2768.90 (2)
| Balance Sheet of Ajanta Pharma (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 11.80 | 11.80 | 11.80 | 11.80 | 11.80 | |
| Total Share Capital | 11.80 | 11.80 | 11.80 | 11.80 | 11.80 | |
| Reserves and Surplus | 173.13 | 145.31 | 123.05 | 103.59 | 96.46 | |
| Total Reserves and Surplus | 173.13 | 145.31 | 123.05 | 103.59 | 96.46 | |
| Total Shareholders Funds | 184.92 | 157.10 | 134.85 | 115.38 | 108.26 | |
| Minority Interest | 0.00 | 0.00 | 0.30 | 0.16 | 0.29 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 143.02 | 151.26 | 93.52 | 51.56 | 44.92 | |
| Deferred Tax Liabilities [Net] | 12.32 | 13.12 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 155.35 | 164.38 | 93.52 | 51.56 | 44.92 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 84.94 | 98.96 | 80.02 | 64.81 | 53.44 | |
| Trade Payables | 69.25 | 45.48 | 42.53 | 29.78 | 30.95 | |
| Other Current Liabilities | 0.07 | 0.05 | 0.04 | 0.03 | 0.01 | |
| Short Term Provisions | 7.62 | 9.44 | 8.64 | 6.55 | 2.92 | |
| Total Current Liabilities | 161.88 | 153.93 | 131.23 | 101.17 | 87.32 | |
| Total Capital And Liabilities | 502.14 | 475.41 | 359.91 | 268.28 | 240.80 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 168.46 | 138.27 | 101.79 | 62.00 | 67.89 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 4.48 | |
| Capital Work-In-Progress | 46.99 | 55.17 | 23.88 | 13.44 | 0.00 | |
| Fixed Assets | 215.45 | 193.44 | 125.67 | 75.44 | 72.37 | |
| Non-Current Investments | 8.47 | 8.47 | 8.47 | 8.47 | 0.01 | |
| Deferred Tax Assets [Net] | 7.05 | 12.55 | 2.93 | 8.55 | 12.39 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 230.97 | 214.45 | 137.06 | 92.46 | 84.77 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 119.62 | 103.89 | 92.77 | 70.84 | 72.37 | |
| Trade Receivables | 96.72 | 100.12 | 86.83 | 68.45 | 63.61 | |
| Cash And Cash Equivalents | 14.84 | 8.07 | 5.76 | 7.45 | 6.72 | |
| Short Term Loans And Advances | 39.99 | 48.88 | 37.48 | 29.08 | 13.32 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 271.18 | 260.96 | 222.84 | 175.81 | 156.03 | |
| Total Assets | 502.14 | 475.41 | 359.91 | 268.28 | 240.80 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 10.43 | 25.65 | 25.14 | 9.60 | 18.47 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 8.47 | 8.47 | 8.47 | 8.47 | 0.01 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
30.12.2025
30.12.2025
26.12.2025
24.12.2025
Ajanta Pharma shares rise 5% on Biocon weight-loss drug marketing pact
10.11.2025
Ajanta Pharma Standalone September 2025 Net Sales at Rs 1,220.24 crore, up 8.09% Y-o-Y
04.11.2025
Ajanta Pharma Consolidated September 2025 Net Sales at Rs 1,353.73 crore, up 14.08% Y-o-Y
29.07.2025
Ajanta Pharma Consolidated June 2025 Net Sales at Rs 1,302.65 crore, up 13.78% Y-o-Y
29.07.2025
Ajanta Pharma Standalone June 2025 Net Sales at Rs 1,208.56 crore, up 12.19% Y-o-Y
12.07.2023
Ajanta Pharma Q1 PAT seen up 9.1% YoY to Rs 190.5 cr: Nirmal Bang
13.07.2022
Ajanta Pharma Q1 PAT may dip 12.7% YoY to Rs 151.6 cr: ICICI Direct
11.01.2019
Ajanta Pharma Q3 PAT may dip 35.1% YoY to Rs. 95.8 cr: ICICI Direct
12.10.2018
Ajanta Pharma Q2 PAT may dip 16.5% YoY to Rs. 110.1 cr: ICICI Direct